glp-1 drugs with fewest side effects which glp 1 has GLP-1: The Diabetes Drug Changing How We Think About Weight Loss Poll: 1 in 8 Adults
Description
While newly approved pharmacotherapies such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) show efficacy, their clinical utility remains constrained by dose-dependent gastrointestinal complications, underscoring the urgent need for safer alternatives

All that follows is from the above resource

Stratified analyses showed no differences between subgroups

Novo-Nordisk A/S, Eli Lilly And Company, Sanofi, AstraZeneca, Pfizer Inc., Amgen, Inc., and Innovent Biologics, Inc
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)